GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
Clinical trial NCT02149225 · COMPLETED
Trial details
- NCT number
- NCT02149225
- Sponsor
- Immatics Biotechnologies GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2018-06-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.